Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes
暂无分享,去创建一个
G. Dimitriadis | I. Andreadou | J. Parissis | A. Bamias | V. Lambadiari | I. Ikonomidis | Fotios Tekos | A. Kountouri | M. Tsoumani | Z. Skaperda | D. Kouretas | K. Katogiannis | F. Kousathana | K. Balampanis | J. Thymis | Christina Chania | C. Chania